QQ客服 官方微博 反馈留言

	BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro
	Tu, Ziwei; Xu, Bingqing; Qu, Chen; Tao, Yalan; Chen, Chen; Hua, Wenfeng; Feng, Guokai; Chang, Hui; Liu, Zhigang; Li, Guo
刊名	Radiation Oncology
	2015
卷号	10期号:1页码:123
关键词	BRCC3 Nasopharyngeal carcinoma Prognostic marker Radioresistance
ISSN号	1748-717X
DOI	10.1186/s13014-015-0427-3
URL标识	查看原文
WOS记录号	WOS:000358343100001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3336490
专题	中南大学
作者单位	1.[Tu, Ziwei 2.Tao, Yalan 3.Chen, Chen 4.Xia, Yunfei 5.Qu, Chen 6.Xu, Bingqing 7.Chang, Hui] Sun Yat Sen Univ, Ctr Canc, Dept Radiat Oncol, Guangzhou 510060, Guangdong, Peoples R China.
推荐引用方式 GB/T 7714	Tu, Ziwei,Xu, Bingqing,Qu, Chen,et al. BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro[J]. Radiation Oncology,2015,10(1):123.
APA	Tu, Ziwei.,Xu, Bingqing.,Qu, Chen.,Tao, Yalan.,Chen, Chen.,...&Xia, Yunfei*.(2015).BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro.Radiation Oncology,10(1),123.
MLA	Tu, Ziwei,et al."BRCC3 acts as a prognostic marker in nasopharyngeal carcinoma patients treated with radiotherapy and mediates radiation resistance in vitro".Radiation Oncology 10.1(2015):123.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。